Elsevier’s SciVal Funding Expands Globally

AMSTERDAM, June 24, 2011 -

Comprehensive
Funding Tool now
Available in Canada, U.K. and
EU

Elsevier, a world-leading provider of scientific, technical and
medical information products and services, today announced the
expansion of SciVal
Funding to regions outside of the United States, enabling
institutions to identify international funding opportunities.

Through the international expansion of SciVal Funding,
researchers, research administrators and research development
professionals in Canada, the United Kingdom and the European Union
will now have access to relevant funding opportunities and awarded
grant data under a single integrated solution. SciVal Funding will
be expanded to Australia in August and to Singapore, South Africa,
India, New Zealand and Ireland by the end of 2011.

“Increasing funding application success rates in today’s
increasingly collaborative and international research community
requires a global perspective and access to appropriate resources,”
said Niels Weertman, Vice-President SciVal, at Elsevier. “The
expanded coverage of funding opportunities and awarded grants
information of SciVal Funding highlights Elsevier’s ongoing
commitment to empower institutions worldwide to implement
performance, planning and funding strategies that are global in
scope and collaborative in nature.”

Recognizing the challenges of increased competition for funding,
Elsevier developed SciVal Funding to optimize the pre-award stage
of the research cycle. The tool leads researchers, research
administrators and research development professionals to grants
with the greatest potential for success by integrating current
funding opportunities with publication information and historical
award data. Updated daily, funding opportunities can be explored by
subject area, award type, deadline or amount. Also, SciVal Funding
provides customized recommendations and alerts by matching funding
opportunity data to pre-populated researcher profiles that are
continuously updated. Research administrators may also use award
information for performance measurement, evaluation and strategic
planning purposes. Access to a comprehensive pool of funding
opportunities as well as the ability to uncover new sources of
financial support is especially critical in these uncertain
economic times.

The inclusion of funding opportunities, award information and
pre-populated researcher profiles from these newly added countries,
as well as the addition of nearly 700 funding bodies to the more
than 3,000 U.S.-based sources currently available in the platform,
will allow institutions to discover international funding
opportunities, resulting in more effective collaboration.

For more information on SciVal Funding and to request a trial,
please visit href="www.info.scival.com">www.info.scival.com.

About the Elsevier SciVal^®
Suite

Elsevier’s SciVal suite ( href="www.info.scival.com">www.info.scival.com)
of services supports academic and government leadership in
evaluating, establishing and executing research strategies that
optimize the performance of existing assets and maximize
investments to enhance near and long-term productivity. SciVal
tools leverage Scopus® data, Elsevier’s trusted source of
bibliometric data, to offer innovative yet authoritative solutions.
Current suite offerings include: SciVal Spotlight™, a strategic
tool that generates unique institutional and country maps of
existing and emerging strengths based on an interdisciplinary
perspective of current performance; SciVal Funding™, an online
solution that provides targeted recommendations on grants to pursue
based on pre-populated research profiles and historical awards;
SciVal Experts, a semantic technology-based application that
enables researchers to identify and locate sources of expertise at
an individual or departmental level within and across
institutions.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in
partnership with the global science and health communities to
publish more than 2,000 journals, including href="www.thelancet.com">The Lancet and href="www.cell.com">Cell, and close to 20,000
book titles, including major reference works from Mosby and
Saunders. Elsevier’s online solutions include href="www.sciencedirect.com/">SciVerse ScienceDirect, href="www.scopus.nl/">SciVerse Scopus, href="www.reaxys.com">Reaxys, href="www.mdconsult.com">MD Consult and href="www.nursingconsult.com">Nursing Consult, which
enhance the productivity of science and health professionals, and
the SciVal suite and href="www.medai.com">MEDai’s Pinpoint Review, which help
research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, href="www.elsevier.com">Elsevier employs 7,000 people
worldwide. The company is part of href="www.reedelsevier.com">Reed Elsevier Group PLC, a
world-leading publisher and information provider, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).

Media contact
Sandra Plasse
+1-212-752-8338
splasse@psbpr.com

.